Derma Sciences Inc. (DSCI) Swings to Q4 Profit
- Top 10 News for 07/21 - 07/25: In the Thick of Earnings; M&A Ramps Up; Where's the Homes?
- Goldman's GOAL Cuts Equities to Neutral, Corporate Credit to Underweight
- Amazon.com, Inc. (AMZN) Posts Q2 Loss of 24c/Share
- IBM (IBM) Rejects Offer for Chip-Making Unit - Bloomberg
- Containerboard Stocks Could Revalue Up to 100% Under MLP Structures, Perry Capital Says (IP) (KS) (RKT)
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- Abbvie, Inc. (ABBV) Tops Q2 EPS by 6c; Guides Q3 EPS to Strong Side
- Aaron's, Inc. (AAN) Posts Q2 EPS of 12c; Guides Q3, FY14 EPS Below Consensus
- Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of Shareholders
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!